Diabetic neuropathy. Diabetes mellitus due to underlying condition with diabetic autonomic (poly)neuropathy
Conditions
Interventions
Intervention 1: Intervention group: Recipients of routine neuropathy drugs, patients who have taken the above drugs for 3 months, and before and after the intervention (3 months after taking the drug)
Sponsors
Birjand University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patient satisfaction to enter the study Having diabetes for more than a year
Exclusion criteria
Exclusion criteria: Having an underlying disease such as myositis Having connective tissue and joint disease Limb amputation Having autoimmune disease Having severe osteoarthritis Malignancy Having fibromyalgia Having kidney and liver failure Patients with ESRD Prolonged diabetes Having vertebral discopathy Having anemia Having hypothyroidism Drug use
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Using the audio-visual pain scale questionnaire.;Symptoms and severity of neuropathy. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: By Using Nerve conduction velocity. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Meysam Javadi
Birjand University of Medical Sciences
Outcome results
None listed